270 related articles for article (PubMed ID: 2466516)
1. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
Sharp T; Bramwell SR; Grahame-Smith DG
Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
[TBL] [Abstract][Full Text] [Related]
3. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity.
Sharp T; Bramwell SR; Clark D; Grahame-Smith DG
J Neurochem; 1989 Jul; 53(1):234-40. PubMed ID: 2470860
[TBL] [Abstract][Full Text] [Related]
4. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
Hjorth S; Sharp T; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
[TBL] [Abstract][Full Text] [Related]
5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
6. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
Sharp T; McQuade R; Bramwell S; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
[TBL] [Abstract][Full Text] [Related]
8. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
Blier P; Serrano A; Scatton B
Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
[TBL] [Abstract][Full Text] [Related]
9. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
Hjorth S
Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
De Souza RJ; Goodwin GM; Green AR; Heal DJ
Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
[TBL] [Abstract][Full Text] [Related]
11. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
[TBL] [Abstract][Full Text] [Related]
12. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
Marsden CA; Martin KF
Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.
Hutson PH; Sarna GS; O'Connell MT; Curzon G
Neurosci Lett; 1989 May; 100(1-3):276-80. PubMed ID: 2474776
[TBL] [Abstract][Full Text] [Related]
14. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
Sharp T; McQuade R; Fozard JR; Hoyer D
Br J Pharmacol; 1993 Jul; 109(3):699-702. PubMed ID: 8102935
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
Peroutka SJ
J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638
[TBL] [Abstract][Full Text] [Related]
16. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
17. The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats.
Bendotti C; Samanin R
Life Sci; 1987 Aug; 41(5):635-42. PubMed ID: 2955189
[TBL] [Abstract][Full Text] [Related]
18. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
19. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity.
Doods HN; Kalkman HO; De Jonge A; Thoolen MJ; Wilffert B; Timmermans PB; Van Zwieten PA
Eur J Pharmacol; 1985 Jun; 112(3):363-70. PubMed ID: 3160596
[TBL] [Abstract][Full Text] [Related]
20. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
Peroutka SJ; Mauk MD; Kocsis JD
Neuropharmacology; 1987; 26(2-3):139-46. PubMed ID: 2884586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
